ETH Zurich

If the body’s natural stress response gets knocked off balance, it can result in physical and mental health disorders. Researchers at ETH Zurich have developed an agent capable of selectively inhibiting this response.

ETH Zurich researchers have found a virus that kills dormant bacteria. This rare discovery could help to combat germs that can’t be treated with antibiotics alone.

Guillain-Barré Syndrome is a rare condition in which a person’s immune system attacks the peripheral nerves. People affected suffer from muscle weakness and paralysis. A research team led by ETH Zurich has now clarified the mechanism of this autoimmune disease.

A new model designed by ETH Zurich researchers measures how flexible medication distribution systems are in real time. It shows that supply shortages can be eased if pharmaceutical wholesalers coordinate their inventories and reroute scarce products as flexibly as possible along existing supply chains.

The Federal Department of Foreign Affairs (FDFA) and ETH Zurich, in collaboration with their international partners, are launching the International Computation and AI Network (ICAIN) at the World Economic Forum (WEF) 2024 in Davos. Its mission is to develop AI technologies that benefit society as a whole, as well as being accessible to all and sustainable, thereby helping to reduce global inequality.